Literature DB >> 15980393

Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.

Todd A Davies1, Karen Bush, Daniel Sahm, Alan Evangelista.   

Abstract

A total of 322 erythromycin-resistant pneumococci from TRUST 3 and TRUST 4 United States surveillance studies (1999-2000) were screened for 23S rRNA, L4, and L22 gene mutations. Nineteen isolates, two with mefA, had mutations at position 2058 or 2059 in 23S rRNA. Two had a 69GTG71-to-TPS substitution in L4; one of these also contained ermA.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15980393      PMCID： PMC1168632          DOI： 10.1128/AAC.49.7.3031-3033.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Emergence of macrolide resistance during treatment of pneumococcal pneumonia.

Authors:  Daniel M Musher; Mark E Dowell; Virginia D Shortridge; Robert K Flamm; James H Jorgensen; Pierre Le Magueres; Kurt L Krause
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  Resistance issues and community-acquired respiratory infections.

Authors:  Daniel F Sahm
Journal:  Clin Cornerstone       Date:  2003

3.  Macrolide resistance among invasive Streptococcus pneumoniae isolates.

Authors:  T B Hyde; K Gay; D S Stephens; D J Vugia; M Pass; S Johnson; N L Barrett; W Schaffner; P R Cieslak; P S Maupin; E R Zell; J H Jorgensen; R R Facklam; C G Whitney
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

4.  Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.

Authors:  Kensuke Nagai; Peter C Appelbaum; Todd A Davies; Linda M Kelly; Dianne B Hoellman; Arjana Tambic Andrasevic; Liga Drukalska; Waleria Hryniewicz; Michael R Jacobs; Jana Kolman; Jolanta Miciuleviciene; Marina Pana; Lena Setchanova; Marianne Konkoly Thege; Helena Hupkova; Jan Trupl; Pavla Urbaskova
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Authors:  Marja Pihlajamäki; Janne Kataja; Helena Seppälä; John Elliot; Maija Leinonen; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

Authors:  G A Syrogiannopoulos; I N Grivea; A Tait-Kamradt; G D Katopodis; N G Beratis; J Sutcliffe; P C Appelbaum; T A Davies
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

Authors:  Todd A Davies; Raul Goldschmidt; Sharon Pfleger; Mike Loeloff; Karen Bush; Daniel F Sahm; Alan Evangelista
Journal:  J Antimicrob Chemother       Date:  2003-07-01       Impact factor: 5.790

9.  Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.

Authors:  Gary V Doern; Steve D Brown
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

10.  Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.

Authors:  D J Farrell; S Douthwaite; I Morrissey; S Bakker; J Poehlsgaard; L Jakobsen; D Felmingham
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191
View more
  5 in total

Review 1.  Genetic elements responsible for erythromycin resistance in streptococci.

Authors:  Pietro E Varaldo; Maria Pia Montanari; Eleonora Giovanetti
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

2.  Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.

Authors:  Ghislaine Descours; Christophe Ginevra; Nathalie Jacotin; Françoise Forey; Joëlle Chastang; Elisabeth Kay; Jerome Etienne; Gérard Lina; Patricia Doublet; Sophie Jarraud
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

3.  New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.

Authors:  Romina Camilli; Maria Del Grosso; Francesco Iannelli; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

Review 4.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Azithromycin resistance mutations in Streptococcus pneumoniae as revealed by a chemogenomic screen.

Authors:  Hélène Gingras; Kévin Patron; Philippe Leprohon; Marc Ouellette
Journal:  Microb Genom       Date:  2020-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.